| WCPD 2012 Haider Obesity |
2012 |
PDF |
🡻 |
| SMSNA 2012 Haider Safety |
2012 |
PDF |
🡻 |
| SMSNA 2012 Haider Obesity |
2012 |
PDF |
🡻 |
| SMSNA 2012 Haider ED LUTS |
2012 |
PDF |
🡻 |
| SIU 2012 Haider ED LUTS |
2012 |
PDF |
🡻 |
| Obesity 2012 Haider Obesity |
2012 |
PDF |
🡻 |
| Norddt. Urologen 2012 Haider ED LUTS |
2012 |
PDF |
🡻 |
| ICDDT 2012 Haider safety |
2012 |
PDF |
🡻 |
| ICAO 2012 Haider Obesity |
2012 |
PDF |
🡻 |
| Goiania 2012 Klinefelter E |
2012 |
PDF |
🡻 |
| Goiania 2012 Haider Safety O |
2012 |
PDF |
🡻 |
| Goiania 2012 Haider Obesity E |
2012 |
PDF |
🡻 |
| Goiania 2012 Haider MetS E |
2012 |
PDF |
🡻 |
| Goiania 2012 Haider ED LUTS E |
2012 |
PDF |
🡻 |
| Goiania 2012 Crohn's disease E |
2012 |
PDF |
🡻 |
| Goiania 2012 Concurrent diseases E |
2012 |
PDF |
🡻 |
| ESSM 2012 Haider Yassin Prostate HP |
2012 |
PDF |
🡻 |
| ESSM 2012 Haider Obesity P |
2012 |
PDF |
🡻 |
| ESSM 2012 Concurrent diseases O |
2012 |
PDF |
🡻 |
| ENDO 2012 Klinefelter S |
2012 |
PDF |
🡻 |
| ENDO 2012 Haider Safety S |
2012 |
PDF |
🡻 |
| ENDO 2012 Haider Obesity S |
2012 |
PDF |
🡻 |
| ENDO 2012 Haider MetS S |
2012 |
PDF |
🡻 |
| ENDO 2012 Haider ED LUTS S |
2012 |
PDF |
🡻 |
| ENDO 2012 Crohn's disease S |
2012 |
PDF |
🡻 |
| ENDO 2012 Concurrent diseases S |
2012 |
PDF |
🡻 |
| EDEC 2012 Klinefelter |
2012 |
PDF |
🡻 |
| EDEC 2012 Haider Safety |
2012 |
PDF |
🡻 |
| EDEC 2012 Haider Obesity |
2012 |
PDF |
🡻 |
| EDEC 2012 Haider MetS |
2012 |
PDF |
🡻 |
| EDEC 2012 Crohn's disease |
2012 |
PDF |
🡻 |
| EDEC 2012 Concurrent diseases |
2012 |
PDF |
🡻 |
| ECO 2012 Obesity |
2012 |
PDF |
🡻 |
| ECE 2012 Haider Safety |
2012 |
PDF |
🡻 |
| ECE 2012 Haider Obesity |
2012 |
PDF |
🡻 |
| ECE 2012 Haider MetS |
2012 |
PDF |
🡻 |
| ECA 2012 Obesity P |
2012 |
PDF |
🡻 |
| ECA 2012 Klinefelter P |
2012 |
PDF |
🡻 |
| ECA 2012 Haider Safety P |
2012 |
PDF |
🡻 |
| ECA 2012 Haider MetS O |
2012 |
PDF |
🡻 |
| ECA 2012 Concurrent diseases P |
2012 |
PDF |
🡻 |
| EAU 2012 Haider 591 |
2012 |
PDF |
🡻 |
| EASD 2012 Saad Haider Obesity |
2012 |
PDF |
🡻 |
| DGU 2012 Haider ED LUTS |
2012 |
PDF |
🡻 |
| ASA 2012 comorbidities |
2012 |
PDF |
🡻 |
| ASA 2012 3 cohorts |
2012 |
PDF |
🡻 |
| ACU 2012 Haider Safety |
2012 |
PDF |
🡻 |
| ACU 2012 Haider ED LUTS |
2012 |
PDF |
🡻 |
| ACU 2012 Concurrent diseases |
2012 |
PDF |
🡻 |
| Yassin 2011 Role of urologist in prevention and early detection of CVD |
2011 |
PDF |
🡻 |
| SMSNA 2011 3 cohorts |
2011 |
PDF |
🡻 |
| SLAMS 2011 Haider 48 mo MetS |
2011 |
PDF |
🡻 |
| SLAMS 2011 Effects of T on AMS and side effects |
2011 |
PDF |
🡻 |
| Saad 2011 Review effects of testosterone on LUTS |
2011 |
PDF |
🡻 |
| Saad 2011 Age, obesity and inflammation at baseline predict the effect of T therapy |
2011 |
PDF |
🡻 |
| Prediabetes 2011_Madrid_T_prediction |
2011 |
PDF |
🡻 |
| IDF 2011 Haider 48 mo |
2011 |
PDF |
🡻 |
| Hohenkammer 2011 2 cohorts |
2011 |
PDF |
🡻 |
| ESSM 2011 3 cohorts |
2011 |
PDF |
🡻 |
| ENDO 2011 Yassin TU CaP risk |
2011 |
PDF |
🡻 |
| ECO 2011 predictors |
2011 |
PDF |
🡻 |
| ECE 2011 Haider safety |
2011 |
PDF |
🡻 |
| ECE 2011 Haider MetS |
2011 |
PDF |
🡻 |
| CURY 2011 Yassin-Haider TU_CaP risk |
2011 |
PDF |
🡻 |
| CURy 2011 Haider safety |
2011 |
PDF |
🡻 |
| CODHy 2011 Haider 48 mo |
2011 |
PDF |
🡻 |
| AUA 2011 Yassin T nonresponders and vardenafil |
2011 |
PDF |
🡻 |
| ASA 2011 Predictors |
2011 |
PDF |
🡻 |
| APSSM 2011 Haider 48 mo |
2011 |
PDF |
🡻 |
| APSSM 2011 3 cohorts |
2011 |
PDF |
🡻 |
| APSSAM 2011 Haider 4 years |
2011 |
PDF |
🡻 |
| Review ED, CVD and T |
2010 |
PDF |
🡻 |
| Publications Andrology |
2010 |
PDF |
🡻 |
| Testosterone improves MetS and liver steatosis |
2010 |
PDF |
🡻 |
| Nebido safety |
2010 |
PDF |
🡻 |
| Nebido in Crohn's disease |
2010 |
PDF |
🡻 |
| Nebido 24 mo safety |
2010 |
PDF |
🡻 |
| Effects of 2 years TU on MetS, NAFLD, and CRP |
2010 |
PDF |
🡻 |
| Concurrent improvement of MetS and LUTS upon T administration |
2009 |
PDF |
🡻 |
| Effects of ADT on glycaemic control and risk factors |
2007 |
PDF |
🡻 |
Deutsch
English
الْعَرَبِيَّة
